3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
3
Prostatic Neoplasms
3
Neoplasms
2
Breast Neoplasms
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Multiple Pulmonary Nodules
1
Multiple Myeloma
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Hodgkin Disease
1
Hepatic Malignancies
1
Head and Neck Neoplasms
1
Glioblastoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Hepatocellular
1
Cancer Diagnosis
1
Breast Cancer Metastases
1
Brain Neoplasms
1
Adenocarcinoma
1
Interventions
Doxorubicin
33
Ifosfamide
23
Gemcitabine
19
pazopanib
18
Cyclophosphamide
16
Radiotherapy
15
pembrolizumab
13
Filgrastim
12
Docetaxel
12
Bevacizumab
10
Vincristine
9
Sirolimus
9
Irinotecan
9
Etoposide
9
olaratumab
7
eribulin
7
Sorafenib
7
Radiation
7
temsirolimus
6
Temozolomide
6
Mesna
6
Magnetic Resonance Spectroscopy
6
Cisplatin
6
tazemetostat
5
cixutumumab
5
Trabectedin
5
Radiosurgery
5
Nivolumab
5
Ipilimumab
5
Granulocyte Colony-Stimulating Factor
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma
×
Positron Emission Tomography Computed Tomography
×
Clear all
No trials found.